Drug Type Monoclonal antibody |
Synonyms XMAB 2513, XMAB2513 |
Target |
Action inhibitors |
Mechanism CD30 inhibitors(Tumor necrosis factor receptor superfamily member 8 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaplastic Large-Cell Lymphoma | Phase 1 | United States | 01 Dec 2007 | |
Hodgkin's Lymphoma | Phase 1 | United States | 01 Dec 2007 |
Phase 1 | Hodgkin's Lymphoma CD30 Positive | 23 | xyhresfvkh(zaixfkhqwl) = hxyrrigvte dnzfvamjus (luoubdrhys ) View more | Negative | 01 Oct 2014 | ||
Phase 1 | 13 | jkzabmbbkl(dhmbnnnryr) = wgwmvurflh jehyvjbbxi (nzjcharpyb ) | - | 20 May 2009 |